发明授权
- 专利标题： Azaindoles for inhibiting aurora2 and other kinases
- 专利标题（中）： 抑制极光2和其他激酶的阿魏酸
-
申请号： US10995103申请日： 2004-11-23
-
公开(公告)号： US07943616B2公开(公告)日： 2011-05-17
- 发明人: Paul J. Cox , Tahir N. Majid , Justine Yeun Quai Lai , Andrew D. Morley , Shelley Amendola , Stephanie D. Deprets , Christopher Edlin , Charles J. Gardner , Dorothea Kominos , Brian L. Pedgrift , Frank Halley , Timothy A. Gillespy , Michael Edwards , Francois F. Clerc , Conception Nemecek , Olivier Houille , Dominique Damour , Herve Bouchard , Daniel N. A. Bezard , Chantal Carrez
- 申请人： Paul J. Cox , Tahir N. Majid , Justine Yeun Quai Lai , Andrew D. Morley , Shelley Amendola , Stephanie D. Deprets , Christopher Edlin , Charles J. Gardner , Dorothea Kominos , Brian L. Pedgrift , Frank Halley , Timothy A. Gillespy , Michael Edwards , Francois F. Clerc , Conception Nemecek , Olivier Houille , Dominique Damour , Herve Bouchard , Daniel N. A. Bezard , Chantal Carrez
- 申请人地址： US NJ Bridgewater
- 专利权人： Aventis Pharmaceuticals Inc.
- 当前专利权人： Aventis Pharmaceuticals Inc.
- 当前专利权人地址： US NJ Bridgewater
- 代理商 Jiang Lin
- 优先权： GB0115109.1 20010621
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/5025 ; A61P29/00 ; A61P35/00 ; A61P19/02
摘要：
The invention is directed to physiologically active compounds of general formula (I):— and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
公开/授权文献
- US20050267304A1 Azaindoles 公开/授权日：2005-12-01
信息查询
